Small molecule T63 suppresses osteoporosis by modulating osteoblast differentiation via BMP and WNT signaling

Xiao-Li Zhao1, Jin-Jing Chen2, Guo-Ning Zhang1

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

Scientific Reports
|September 6, 2017
PubMed

Insights

A novel compound, T63, effectively promotes osteogenesis by up-regulating Runt-related transcription factor 2 (RUNX2) and bone formation. This compound shows promise for treating osteoporosis by restoring bone remodeling balance.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoporosis is characterized by an imbalance in bone remodeling, specifically between bone resorption and formation.
  • Developing effective treatments to restore normal bone remodeling is crucial for managing osteoporosis.

Purpose of the Study:

  • To identify novel small-molecule compounds that can promote osteogenesis.
  • To investigate the therapeutic potential of a newly identified compound, T63, for osteoporosis treatment.

Main Methods:

  • Utilized a cell-based high-throughput screening model for Runt-related transcription factor 2 (RUNX2) activity.
  • Assessed T63's effects on osteoblast differentiation, mineralization, and gene expression in vitro.
  • Evaluated T63's efficacy in established rat models of osteoporosis.

Main Results:

  • T63 significantly increased alkaline phosphatase (ALPL) activity, mineralization, and osteogenic gene expression.
  • T63 inhibited adipogenic differentiation and up-regulated RUNX2 at both mRNA and protein levels.
  • T63 treatment protected against bone mass loss in ovariectomized and dexamethasone-induced osteoporosis models.

Conclusions:

  • T63 is a potent up-regulator of osteogenesis, acting through RUNX2, BMPs, and WNT/β-catenin signaling pathways.
  • T63 demonstrates significant therapeutic potential for osteoporosis and warrants further clinical development.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.0K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K